CompletedNot Applicable

High Velocity Nasal Insufflation (Hi-VNI) Use in Upper Airway Surgery

United States31 participantsStarted 2020-10-22

Plain-language summary

The goals of this study are to establish the efficacy of Hi-VNI (High Velocity Nasal Insufflation) in upper airway surgery from the anesthesiologist's and surgeon's perspectives, and to describe the ideal patient and the ideal pathology as well as suitable clinical scenarios when this oxygenation technique should be selected.

Who can participate

Age range22 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Scheduled to undergo elective upper airway surgery at the University of Pennsylvania Exclusion Criteria: * Underlying medical conditions in which brief periods of hypoxemia or hypercarbia are not well tolerated * Coronary artery disease * Severe heart failure with EF \< 40% or implanted ICD * Pulmonary hypertension or pulmonary fibrosis * History of increased intracranial pressure * History of skull base or intracranial surgery * Severe nasal obstruction * Extremely low or extremely high BMI (BMI \<16 or \>40) * At high risk for aspiration * Taken to OR for urgent or emergent upper airway surgery

What they're measuring

Surgical Case Completion Rate Using HVNI With or Without Converting to Alternative Mode of Oxygenation

Timeframe: 1 day

Trial details

NCT IDNCT05090852

SponsorNatasha Mirza

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-09-30

Results submitted2022-07-25

View on ClinicalTrials.gov More Upper Airway Surgery trials